A Systemic Disquisition on Pancreatic Neoplasia in all age groups: An Exhaustive Appraisal of Diagnostic Stratification, Histopathological Paradigms, and the Multimodal Oncotherapeutic Spectrum based on 13 high end studies
Keywords:
Pancreatic Neoplasms, PDAC, Molecular Diagnostics, Histopathology, FOLFIRINOX, PARP Inhibitors, EUS-FNA, Targeted Therapy, Precision Oncology, Neoadjuvant Chemotherapy, Tumor Microenvironment, Pancreatic Surgery, 68Ga-DOTATATE PET/CT, Liquid Biopsy, KRASAbstract
Pancreatic neoplasms represent one of the most insidious and biologically aggressive oncological entities, often eluding early detection and exhibiting dismal prognostication despite evolving molecular and therapeutic frontiers. This systematic review synthesizes evidence from 13 pivotal, high-impact studies to elucidate the diagnostic modalities, histopathological intricacies, and advanced oncologic treatment modalities—including chemotherapeutic regimens, molecular-targeted therapies, and surgical innovations—in pancreatic malignancies. Through comprehensive analysis, this review seeks to integrate clinical, histomolecular, and therapeutic determinants into a cohesive algorithm for contemporary management
Downloads
References
Sung H, et al. CA Cancer J Clin. 2021;71(3):209–249.
Hruban RH, et al. Nat Rev Clin Oncol. 2019;16(7):457–470.
Waddell N, et al. Nature. 2015;518(7540):495–501.
Cohen JD, et al. Science Transl Med. 2017;9(403):eaal5243.
Bailey P, et al. Nature. 2016;531(7592):47–52.
del Chiaro M, et al. J Gastrointest Surg. 2020;24(5):1042–1050.
Kubo H, et al. Endoscopy. 2022;54(4):360–368.
Conroy T, et al. N Engl J Med. 2011;364(19):1817–1825.
Von Hoff DD, et al. N Engl J Med. 2013;369(18):1691–1703.
Golan T, et al. N Engl J Med. 2019;381(4):317–327.
Beatty GL, et al. Sci Transl Med. 2015;7(283):283ra52.
Versteijne E, et al. J Clin Oncol. 2020;38(16):1763–1773.
Hingorani SR, et al. J Clin Oncol. 2018;36(4):359–366
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.